QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection

Francesca Saluzzo; Paola Mantegani; Valeria Poletti de Chaurand; Daniela Maria Cirillo

doi:10.1183/13993003.02563-2021

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection

Eur Respir J. 2022 Mar 24;59(3):2102563. doi: 10.1183/13993003.02563-2021. Print 2022 Mar.

Authors

Francesca Saluzzo^{1

2}, Paola Mantegani^{1

2}, Valeria Poletti de Chaurand¹, Daniela Maria Cirillo³

Affiliations

¹ Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² These authors contributed equally to this work.
³ Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy cirillo.daniela@hsr.it.

Abstract

QIAreach QFT demonstrated a good performance in diagnosing TB infection. This tool may offer technical and operational benefits over more complex IGRA ELISA-based assays, granting timely TB diagnosis in decentralised settings with limited infrastructure. https://bit.ly/3n6Dxll

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Interferon-gamma Release Tests
Latent Tuberculosis* / diagnosis
Mycobacterium tuberculosis*
Tuberculin Test
Tuberculosis* / diagnosis
Tuberculosis* / microbiology